Rare diseases
Investigational molecules
Locations
Study of levetiracetam to prevent seizures in adults who have both Down syndrome and Alzheimer's disease
SpainStudy of anti-seizure drug combination in comatose patients with status epilepticus after cardiac arrest
BelgiumStudy on Anti-CD19 CAR T-Cell Therapy for Patients with Refractory Systemic Autoimmune Diseases Using Levetiracetam, Fludarabine, and a Drug Combination
ItalyStudy on Fast Sedation with Propofol and Midazolam vs. Anti-Seizure Drug Combination for Treating Refractory Status Epilepticus in Intensive Care Patients
DenmarkA Study of Levetiracetam for Prevention and Treatment of Delirium in Adult ICU Patients with Septic Shock
FranceStudy on the Safety and Dosage of GD2IL18CART for Patients with Relapsed or Refractory GD2 Positive Solid Cancers
GermanyStudy evaluating the effect of levetiracetam on recovery in patients with intracerebral haemorrhage
FranceA study to evaluate the safety and effectiveness of subcutaneous blinatumomab in adults and adolescents with relapsed, refractory, or minimal residual disease positive B-cell precursor acute lymphoblastic leukemia.
BelgiumStudy on Treating Status Epilepticus in Seniors Using Levetiracetam and Valproate Semisodium
GermanyStudy on the Effectiveness and Safety of Levetiracetam XR for Patients with Drug-Resistant Partial Onset Epilepsy
BulgariaStudy on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
ItalyStudy on the Safety and Effectiveness of MB-CART2019.1 for Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma
CroatiaTell us about your condition – we search every trial in Europe and connect you with the right site.
